Novel altruistic stem cell defense mechanism may be targeted to develop new COVID-19 vaccines

By | June 17, 2021
The SARS-CoV-2 virus that causes COVID-19 may have the ability to reactivate dormant tuberculosis (TB). In a novel study scientists report in The American Journal of Pathology that infection with a specific coronavirus strain reactivated dormant Mycobacterium tuberculosis (MTB) in mice.